Our Company Profile
In February 2011, Valeant Pharmaceuticals
International, Inc. and PharmaSwiss S.A., announced their agreement for Valeant
to acquire PharmaSwiss, a privately-owned branded generics and over-the-counter
(OTC) pharmaceutical company based in Zug, Switzerland. The acquisition was
complete in March 2011. PharmaSwiss has a broad product portfolio in seven
therapeutic areas and operations in nineteen countries throughout Central and
Eastern Europe, including Poland, Hungary, the Czech Republic and Serbia. The
company also has operations in Greece and Israel. PharmaSwiss had annual
revenues of approximately euro 180 million in 2010 and has been growing at
approximately 20% per year over the past 5 years.
PharmaSwiss employs
approximately 760 employees spread across its 19 countries, operating an EU GMP
capsuling and packaging facility which is being significantly expanded and
backwards-integrated. In addition, PharmaSwiss is an existing partner to several
large pharmaceutical and biotech companies offering regional expertise in such
functions as regulatory, compliance, sales, marketing and distribution.
More about our company